Joanne L. Mitchell

Birmingham, ENG B152TT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Comparing anti-platelet and anti-thrombin therapies in the ischaemia-reperfusion injured coronary microcirculation of healthy and diabetic mice.

Comparing anti-platelet and anti-thrombin therapies in the ischaemia-reperfusion injured coronary microcirculation of healthy and diabetic mice.

Journal: Basic research in cardiology

Published: October 27, 2025

Recombinant von Willebrand Factor (vonicog alfa) reduces platelet inhibition caused by antiplatelet drugs and has potential as an acute haemostatic agent.

Recombinant von Willebrand Factor (vonicog alfa) reduces platelet inhibition caused by antiplatelet drugs and has potential as an acute haemostatic agent.

Journal: Haematologica

Published: September 16, 2025

TRIPLE Score: GPVI and CD36 Expression Predict a Prothrombotic Platelet Function Phenotype.

TRIPLE Score: GPVI and CD36 Expression Predict a Prothrombotic Platelet Function Phenotype.

Journal: Circulation research

Published: January 22, 2025

Editorial expression of concern: Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis.

Editorial expression of concern: Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis.

Journal: Thrombosis journal

Published: December 05, 2024

Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis.

Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis.

Journal: Thrombosis journal

Published: December 24, 2023

Dietary n-3 polyunsaturated fatty acids alter the number, fatty acid profile and coagulatory activity of circulating and platelet-derived extracellular vesicles: a randomized, controlled crossover trial.

Dietary n-3 polyunsaturated fatty acids alter the number, fatty acid profile and coagulatory activity of circulating and platelet-derived extracellular vesicles: a randomized, controlled crossover trial.

Journal: The American journal of clinical nutrition

Published: December 01, 2023

Multiple myeloma and its treatment contribute to increased platelet reactivity.

Multiple myeloma and its treatment contribute to increased platelet reactivity.

Journal: Platelets

Published: October 12, 2023

Interleukin-36 is vasculoprotective in both sexes despite sex-specific changes in the coronary microcirculation response to IR injury.

Interleukin-36 is vasculoprotective in both sexes despite sex-specific changes in the coronary microcirculation response to IR injury.

Journal: Frontiers in cardiovascular medicine

Published: May 23, 2023

Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability.

Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability.

Journal: Research and practice in thrombosis and haemostasis

Published: November 24, 2022

The rate of platelet activation determines thrombus size and structure at arterial shear.

The rate of platelet activation determines thrombus size and structure at arterial shear.

Journal: Journal of thrombosis and haemostasis : JTH

Published: November 03, 2022

Cucurbitacins Elicit Anti-Platelet Activity via Perturbation of the Cytoskeleton and Integrin Function.

Cucurbitacins Elicit Anti-Platelet Activity via Perturbation of the Cytoskeleton and Integrin Function.

Journal: Thrombosis and haemostasis

Published: March 07, 2022

Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets.

Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets.

Journal: Blood

Published: March 29, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026